Friday, July 10, 2026

biotech

Kamada BioPharma Limited

Kamada BioPharma Limited drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

GB HQ
EMA registrant Type
Company details
Status
Public
HQ
GB
Programs
1
Drugs
3
Patents
0
Intelligence · Drug Pipeline

Kamada BioPharma Limited pipeline

Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Kamada BioPharma Limited drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

3 compounds
  1. Development asset linked to Kamada BioPharma Limited in public FDA and regional records.

  2. Development asset linked to Kamada BioPharma Limited in public FDA and regional records.

  3. Development asset linked to Kamada BioPharma Limited in public FDA and regional records.